General
Preferred name
REGADENOSON
Synonyms
Rapiscan ()
Regadenoson monohydrate ()
CVT-3146 ()
Lexiscan ()
Regadenoson hydrate ()
P&D ID
PD077773
CAS
875148-45-1
Tags
available
drug
Drug Status
approved
Max Phase
4.0
Drug indication
Cardiovascular disease
First approval
2008
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
120
DESCRIPTION
Regadenoson is an A2A adenosine receptor agonist, a coronary vasodilator commonly used in pharmacologic stress testing.
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
2
ChEMBL Approved Drugs
ChEMBL Drugs
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
8
Molecular Weight
408.15
Hydrogen Bond Acceptors
12
Hydrogen Bond Donors
5
Rotatable Bonds
4
Ring Count
4
Aromatic Ring Count
3
cLogP
-3.26
TPSA
217.96
Fraction CSP3
0.4
Chiral centers
4.0
Largest ring
6.0
QED
0.29
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Source data
